ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure

ARTBIO Denmark Finland France Germany Netherlands Sweden United Kingdom Norway Massachusetts

View original content:https://www.prnewswire.co.uk/news-releases/artbio-announces-132-million-series-b-financing-to-advance-pipeline-of-alpha-radioligand-therapies-and-expand-manufacturing-and-supply-chain-infrastructure-302515367.html